These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10502631)

  • 1. Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets.
    Macleod GS; Fell JT; Collett JH; Sharma HL; Smith AM
    Int J Pharm; 1999 Oct; 187(2):251-7. PubMed ID: 10502631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma scintigraphic evaluation of film-coated tablets intended for colonic or biphasic release.
    Ofori-Kwakye K; Fell JT; Sharma HL; Smith AM
    Int J Pharm; 2004 Feb; 270(1-2):307-13. PubMed ID: 14726145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery.
    Turkoglu M; Ugurlu T
    Eur J Pharm Biopharm; 2002 Jan; 53(1):65-73. PubMed ID: 11777754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leaching of pectin from mixed films containing pectin, chitosan and HPMC intended for biphasic drug delivery.
    Ofori-Kwakye K; Fell JT
    Int J Pharm; 2003 Jan; 250(1):251-7. PubMed ID: 12480290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro investigation into the potential for bimodal drug release from pectin/chitosan/HPMC-coated tablets.
    Macleod GS; Fell JT; Collett JH
    Int J Pharm; 1999 Oct; 188(1):11-8. PubMed ID: 10528078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture.
    Ugurlu T; Turkoglu M; Gurer US; Akarsu BG
    Eur J Pharm Biopharm; 2007 Aug; 67(1):202-10. PubMed ID: 17337171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic drug release: the permeability of films containing pectin, chitosan and HPMC.
    Ofori-Kwakye K; Fell JT
    Int J Pharm; 2001 Sep; 226(1-2):139-45. PubMed ID: 11532577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose.
    Nunthanid J; Huanbutta K; Luangtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 Feb; 68(2):253-9. PubMed ID: 17616377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric coated HPMC capsules designed to achieve intestinal targeting.
    Cole ET; Scott RA; Connor AL; Wilding IR; Petereit HU; Schminke C; Beckert T; Cadé D
    Int J Pharm; 2002 Jan; 231(1):83-95. PubMed ID: 11719017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
    Newton AM; Lakshmanan P
    Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colon delivery of prednisolone based on chitosan coated polysaccharide tablets.
    Park HS; Lee JY; Cho SH; Baek HJ; Lee SJ
    Arch Pharm Res; 2002 Dec; 25(6):964-8. PubMed ID: 12510854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of neutron activation factors on matrix tablets for site specific delivery to the colon.
    Ahrabi SF; Heinämäki J; Sande SA; Graffner C
    Eur J Pharm Sci; 2000 May; 10(3):225-35. PubMed ID: 10767600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of a pH-, microbiota- and time-based oral delivery platform for colonic release.
    Moutaharrik S; Maroni A; Neut C; Dubuquoy C; Dubuquoy L; Foppoli A; Cerea M; Palugan L; Siepmann F; Siepmann J; Gazzaniga A
    Eur J Pharm Biopharm; 2023 Feb; 183():13-23. PubMed ID: 36563887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder.
    Krögel I; Bodmeier R
    J Control Release; 1999 Aug; 61(1-2):43-50. PubMed ID: 10469901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of shellac-coated anthocyanin pectin beads as dietary colonic delivery system.
    Oehme A; Valotis A; Krammer G; Zimmermann I; Schreier P
    Mol Nutr Food Res; 2011 May; 55 Suppl 1():S75-85. PubMed ID: 21538844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers.
    Hodges LA; Connolly SM; Band J; O'Mahony B; Ugurlu T; Turkoglu M; Wilson CG; Stevens HN
    Int J Pharm; 2009 Mar; 370(1-2):144-50. PubMed ID: 19114096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite film-coated tablets intended for colon-specific delivery of 5-aminosalicylic acid: using deesterified pectin.
    Sriamornsak P; Nunthanid J; Wanchana S; Luangtana-Anan M
    Pharm Dev Technol; 2003 Aug; 8(3):311-8. PubMed ID: 12901696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release.
    Macleod GS; Collett JH; Fell JT
    J Control Release; 1999 Apr; 58(3):303-10. PubMed ID: 10099155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral mucosal bioadhesive tablets of pectin and HPMC: in vitro and in vivo evaluation.
    Miyazaki S; Kawasaki N; Nakamura T; Iwatsu M; Hou WM; Attwood D
    Int J Pharm; 2000 Aug; 204(1-2):127-32. PubMed ID: 11011995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.